BioAtla, Inc. (BCAB): Nasdaq/NYSE listing notice — BioAtla receives Nasdaq delisting notice for failing $10M equity requirement

BioAtla, Inc.

Stockholders' equity was $547K as of March 31, 2025, far below the $10M minimum for Nasdaq Global Market.
Company has until June 26, 2025 to submit a compliance plan; Nasdaq may grant a 180-day extension.
No immediate delisting effect; company intends to submit plan and take reasonable measures to regain compliance.
Also failed alternative compliance standards based on market value of listed securities or total assets and revenue.
Risk of delisting persists if plan is not accepted or compliance not regained within any granted period.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

BioAtla, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5450(b)(1)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5450(b)(1)(A)

Exact text from the filing

May 12, 2025, BioAtla, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Staff of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that because the Company’s stockholders’ equity was $547,000 as of March 31, 2025, as reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, it was no longer in compliance with the $10,000,000 minimum stockholders’ equity requirement for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(1)(A) (the “Minimum Stockholder Equity Requirement”), and th

View on SEC.gov

Browse all listing & compliance notices →

BioAtla, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-073688

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.